Clinical
Sites
Our research sites are outfitted with cutting-edge facilities and staffed by seasoned clinical teams committed to executing trials with precision and in strict accordance with the highest industry standards Everywhere we are present.
CRU Global conducts clinical trials within its dedicated early-phase units, Phase 1 units, and later-phase inpatient and outpatient clinics. To accommodate the growing number of study requests and the need for specialized patient populations, CRU Global has established and manages several partner sites, as well as preferred partnerships with select facilities.
Our partner sites include renowned and experienced university clinics, university hospitals, national institutes, and hospitals, all of which are home to numerous Key Opinion Leaders.
Phase I-IV Clinical Trials
Country feasibility, site and investigator selections are crucial steps for any clinical trials, as it impacts the study for its whole duration.
- Over 350 Phase I to Phase III studies completed
- 35 - 40 new studies initiated per year
- More than 5000 subjects randomized in the in the last few years
- Up to now 2 regulatory inspections by FDA and 5 inspections by National Regulatory 📊 Authority
- Over 45 sponsor and CRO audits successfully completed
- Worldwide top enroller in 20% of the studies in many different indications
- Patient retention is over 98%
- Contracted recruitment targets reached over 95% of the cases
- Therapeutic areas: healthy volunteers, pulmonology, oncopulmonology, cardiology, diabetology, lipidology, rheumatology, gastroenterology, infectology, gynecology, dermatology, neurology, psychiatry
- Inhouse radiology (DXA, X-ray, CT, MRI) and laboratory (safety lab, serology, molecular biology) services
- Investigator Initiated Trials (IITs)
Early Development
Trials
- Phase I – II Proof-of-Concept [POC]
- Adaptive design studies: healthy volunteer & patient
- First in Human [FIH]
- Single Ascending Dose [SAD]
- Multiple Ascending Dose [MAD]
- Bioavailability/ Bioequivalence [BA/BE]
- Pharmacokinetics/ Pharmacodynamics [PK/PD]
- Dose ranging and Tolerability studies
- Food Effect studies
- Drug-Drug Interaction studies
Partner Sites
For rare diseases, niche indications, or fast-track recruitment, CRU-GLOBAL activates top-tier partner sites—leading academic centers and university clinics with KOL investigators. These sites, affiliated with local CRU offices, offer high recruitment potential, and studies are fully or partly managed by CRU to ensure appropriate oversight, quality and speed in delivery.